MTOR and renal cell carcinoma: In addition, M2 TAMs-loaded miR-342-3p could intensely drive the proliferation, migration, and invasion capacity of RCC cells by activating the PI3K/AKT/mammalian target of rapamycin (mTOR) signaling pathway [54].